About this trial
This study aims to evaluate the role of stroke protocol in the early diagnosis and management of acute stroke and its effect on turnaround time (TAT) in emergency settings.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years.
Both sexes.
Patients with acute stroke who are admitted to the emergency department.
Disqualifiers
Contraindications to magnetic resonance imaging (MRI) or computed tomography (CT).
Symptoms strongly suggestive of subarachnoid hemorrhage.
Initiation of antithrombotic or thrombolytic treatment before the completion of both scans.
Inability to complete both scans in time to allow thrombolytic treatment within three h of the onset of symptoms.
Trial population
This prospective cohort study will be carried out on 136 patients presenting with acute stroke symptoms after approval from the institutional ethical committee.
Trial design
Cohort
Prospective
Treatments tested in this trial
Magnetic Resonance Imaging
DeviceMagnetic Resonance Imaging will be performed to all patients
Treatment groups
Trial outcomes
Primary outcomes
Sensitivity of magnetic resonance imaging for acute stroke
Sensitivity of magnetic resonance imaging for acute stroke will be recorded.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.